Peptides & Peptide Synthesis Products

Fmoc-Glu-OtBu

Fmoc-Glu-OtBu
$40.00
$40.00
Fmoc-Glu-OtBu, Catalog No: 41072
Nα-Fmoc-L-glutamic acid α-tert-butyl ester, CAS: 84793-07-7, MW: 425.47, Formula: C24H27NO6
Catalog No: 41072
Nα-Fmoc-L-glutamic acid α-tert-butyl ester, CAS: 84793-07-7, MW: 425.47, Formula: C24H27NO6
Description

Details

Nα-Fmoc-L-glutamic acid α-tert-butyl ester
Additional Information

Additional Information

Catalog Number 41072
CAS 84793-07-7
M.W. 425.47
Formula C24H27NO6
IUPAC Name (4S)-4-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoic acid
Synonym Nα-Fmoc-L-glutamic acid α-tert-butyl ester
Also Known As
  • (4S)-4-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoic acid
  • (4S)-5-tert-butoxy-4-(9H-fluoren-9-ylmethoxycarbonylamino)-5-oxo-pentanoic acid
  • (4S)-5-tert-butoxy-4-[(9H-fluoren-9-ylmethoxy-oxomethyl)amino]-5-oxopentanoic acid
  • (4S)-5-tert-butoxy-4-(9H-fluoren-9-ylmethoxycarbonylamino)-5-keto-valeric acid
  • (4S)-4-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxy]-5-oxo-pentanoic acid
InChIKey GOPWHXPXSPIIQZ-FQEVSTJZSA-N
InChI InChI=1S/C24H27NO6/c1-24(2,3)31-22(28)20(12-13-21(26)27)25-23(29)30-14-19-17-10-6-4-8-15(17)16-9-5-7-11-18(16)19/h4-11,19-20H,12-14H2,1-3H3,(H,25,29)(H,26,27)/t20-/m0/s1
SMILES CC(C)(C)OC(=O)[C@H](CCC(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13
Cited Uses

Details

1. Wong CT et al, "Realizing serine/threonine ligation: scope and limitations and mechanistic implication thereof", Frontiers in Chemistry, 2() pp.28 ().
2. Pipkorn R et al, "A Peptide & Peptide Nucleic Acid Synthesis Technology for Transporter Molecules and Theranostics - The SPPS", International Journal of Medical Sciences, 11(7) pp.697-706 ().
3. Pravetoni M et al, "Effect of Currently Approved Carriers and Adjuvants on the Pre-Clinical Efficacy of a Conjugate Vaccine against Oxycodone in Mice and Rats", PLoS ONE, 9(5) pp.e96547 ().
4. Krantz A et al, "Site-specific Labeling of a Protein Lysine Residue By Novel Kinetic Labeling Combinatorial Libraries", Computational and Structural Biotechnology Journal, 9() pp.e201403001 ().
5. Trevaskis JL et al, "Improved Glucose Control and Reduced Body Weight in Rodents with Dual Mechanism of Action Peptide Hybrids", PLoS ONE, 8(10) pp.e78154 ().
6. Ward BP et al, "Peptide lipidation stabilizes structure to enhance biological function", Molecular Metabolism, 2(4) pp.468-479 ().
7. Witte MD et al, "Production of unnaturally linked chimeric proteins using a combination of sortase-catalyzed transpeptidation and click chemistry", Nature protocols, 8(9) pp.1808-1819 (2013 Sep).
8. Theile CS et al, "Site-specific N-terminal labeling of proteins using sortase-mediated reactions", Nature protocols, 8(9) pp.1800-1807 (2013 Sep).
9. Wissner RF et al, "Labeling Proteins with Fluorophore/Thioamide FRET Pairs by Combining Unnatural Amino Acid Mutagenesis and Native Chemical Ligation", Journal of the American Chemical Society, 135(17) pp.6529-6540 (2013 May 1).
10. Shirazi AN et al, "Efficient Delivery of Cell Impermeable Phosphopeptides by a Cyclic Peptide Amphiphile Containing Tryptophan and Arginine", Molecular pharmaceutics, 10(5) pp.2008-2020 (2013 May 6).
11. Thakkar A et al, "Global Analysis of Peptide Cyclization Efficiency", ACS combinatorial science, 15(2) pp.120-129 (2013 Feb 11).
12. Gunasekera S et al, "Making Ends Meet: Microwave-Accelerated Synthesis of Cyclic and Disulfide Rich Proteins Via In Situ Thioesterification and Native Chemical Ligation", International Journal of Peptide Research and Therapeutics, 19(1) pp.43-54 (2013 Mar).
13. Merkx R et al, "Synthesis and Evaluation of a Selective Fluorogenic Pup Derived Assay Reagent for Dop, a Potential Drug Target in Mycobacterium tuberculosis", Chembiochem, 13(14) pp.2056-2060 (2012 Sep 24).
14. Wu X et al, "Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer", Bioconjugate chemistry, 23(8) pp.1548-1556 (2012 Aug 15).
15. Fruchart-Gaillard C et al, "Engineering of Three-Finger Fold Toxins Creates Ligands with Original Pharmacological Profiles for Muscarinic and Adrenergic Receptors", PLoS ONE, 7(6) pp.e39166 ().
16. Newcomb CJ et al, "The Role of Nanoscale Architecture in Supramolecular Templating of Biomimetic Hydroxyapatite Mineralization", Small (Weinheim an Der Bergstrasse, Germany), 8(14) pp.2195-2202 (2012 Jul 23).
17. Batjargal S et al, "Native Chemical Ligation of Thioamide-Containing Peptides: Development and Application to the Synthesis of Labeled ?-Synuclein for Misfolding Studies", Journal of the American Chemical Society, 134(22) pp.9172-9182 (2012 Jun 6).
18. Bahta M et al, "Oxime-based linker libraries as a general approach for the rapid generation and screening of multidentate inhibitors", Nature protocols, 7(4) pp.686-702 ().
19. Li Y et al, "Opioid glycopeptide analgesics derived from endogenous enkephalins and endorphins", Future Medicinal Chemistry, 4(2) pp.205-226 (2012 Feb).
20. Rothbart SB et al, "Peptide Microarrays to Interrogate the Histone Code", Methods in enzymology, 512() pp.107-135 (2012).
21. Miller SE et al, "Reversible ?-helix formation controlled by a hydrogen bond surrogate", Tetrahedron, 68(23) pp.4434-4437 (2012 Jun 10).
22. Nagorny P et al, "Probing the Frontiers of Glycoprotein Synthesis: The Fully Elaborated ?-subunit of the Human Follicle-Stimulating Hormone", Angewandte Chemie (International Ed. in English), 51(4) pp.975-979 (2012 Jan 23).
23. Schroll AL et al, "2,2?-Dithiobis(5-nitropyridine) (DTNP) as an Effective and Gentle Deprotectant for Common Cysteine Protecting Groups", Journal of Peptide Science, 18(1) pp.1-9 (2012 Jan).
24. Soukasene S et al, "Anti-Tumor Activity of Peptide Amphiphile Nanofiber-Encapsulated Camptothecin", ACS nano, 5(11) pp.9113-9121 (2011 Nov 22).
25. Dong S et al, "Toward Homogeneous Erythropoietin: Application of Metal Free Dethiylation in the Chemical Synthesis of the Ala79-Arg166 Glycopeptide Domain", Israel journal of chemistry, 51(8-9) pp.968-976 (2011 Nov).
Reviews
cr